Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

BACKGROUND: The intestinal uptake of the taxanes paclitaxel and docetaxel is seriously hampered by drug efflux through P-glycoprotein (P-gp) and drug metabolism via cytochrome P450 (CYP) 3A. The resulting low oral bioavailability can be boosted by co-administration of P-gp or CYP3A4 inhibitors. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrikx, J J M A, Lagas, J S, Wagenaar, E, Rosing, H, Schellens, J H M, Beijnen, J H, Schinkel, A H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037831/
https://www.ncbi.nlm.nih.gov/pubmed/24781280
http://dx.doi.org/10.1038/bjc.2014.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037831/
https://www.ncbi.nlm.nih.gov/pubmed/24781280
http://dx.doi.org/10.1038/bjc.2014.222

Ejemplares similares